Document is current
Any future updates will be listed below
-
Authors
Demir, Ihsan Ekin https://orcid.org/0000-0001-8241-1871
Mota Reyes, Carmen
Alrawashdeh, Wasfi
Ceyhan, Güralp O.
Deborde, Sylvie https://orcid.org/0000-0002-6630-4029
Friess, Helmut
Görgülü, Kıvanç https://orcid.org/0000-0002-1613-1422
Istvanffy, Rouzanna
Jungwirth, David
Kuner, Rohini
Maryanovich, Maria
Na’ara, Shorook
Renders, Simon
Saloman, Jami L. https://orcid.org/0000-0001-6093-6511
Scheff, Nicole N.
Steenfadt, Hendrik
Stupakov, Pavel
Thiel, Vera
Verma, Divij
Yilmaz, Bengi Su
White, Ruth A. https://orcid.org/0000-0002-4274-4468
Wang, Timothy C.
Wong, Richard J.
Frenette, Paul S.
Gil, Ziv
,
Davis, Brian M.
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DE2428/7-1)
Fritz Thyssen Stiftung (30.19.0.128MN)
Verein für wissenschaftliche Fachtagungen in der Biomedizin e.V. / VWFB e.v; www.vwfb.de
- License Information
-
More Information
Article History
First Online: 17 November 2020
Competing interests
: T.C.W. is a Consultant for Novo Nordisc and Glaxo SmithKline and is on the Scientific Advisory Board for Cygnal Therapeutics.
